News tagged with erlotinib

Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer

Head and neck cancers respond well to the anti-cancer drug erlotinib when it is administered before surgery and a stronger dose is given to patients who smoke, according to a study presented at the Multidisciplinary Head ...

Addiction Jan 26, 2012 | not rated yet | 0

EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapy

In the first phase III study to include Western lung cancer patients, first-line treatment with erlotinib (Tarceva) nearly doubled progression-free survival compared with chemotherapy, according to research presented at the ...

Cancer Jul 05, 2011 | not rated yet | 0

PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumors

A non-invasive PET imaging technique may identify lung cancers that respond best to tyrosine kinase inhibitors (TKIs), allowing doctors to better select patients for personalized therapy, according to research presented at ...

Cancer Jul 05, 2011 | not rated yet | 0

A drug combination extends survival in refractory lung cancer patients

Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies. They found that bexarotene and erlotinib can each ...

Cancer Jun 02, 2011 | not rated yet | 0

Less toxic combination of erlotinib and bevacizumab is effective non-small cell lung cancer patients

The standard treatment for patients with advanced non-small cell lung cancer (NSCLC) is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity. Now, Fox ...

Cancer Jun 01, 2011 | not rated yet | 0

Asian lung cancer patient survival exceeds Caucasians' on multiple regimens

Asian non-small cell lung cancer (NSCLC) patients survive longer than Caucasians no matter how many drugs are given in a first-line setting, and the effect was apparent both before and after the introduction of targeted therapies ...